📰 Newspapers

Trump administration weighs Marshall for FDA as Overton wobbles

Trump administration weighs Marshall for FDA as Overton wobbles

The Kansas Republican senator, who just lost his reelection bid, is seen as a stronger potential nominee.

The Scoop

Republicans are discussing Sen. Roger Marshall as a potential replacement nominee to lead the Food and Drug Administration as Heidi Overton’s confirmation struggles in the Senate, according to four people familiar with the matter.

The Kansas Republican, who just lost his reelection bid, is seen as a stronger potential nominee than Overton, who faces opposition from both anti-abortion activists and moderate Republicans in her bid to lead the agency. Republicans face a severe time crunch if Overton’s nomination is pulled or fails in committee; they have a month and a half left in the majority to confirm President Donald Trump’s nominees.

“Marshall is viewed as an alternative if Heidi can’t make it through,” a Trump administration official told Semafor. “Senators have an easier time getting confirmed, traditionally. At this point, it’s hard to get anyone approved.”

The Senate health committee is scheduled to vote on Overton’s nomination on Wednesday.

Marshall, a doctor who served two terms in the House before his Senate election in 2020, currently serves on the health committee.

It’s unclear how quickly the White House might move on any alternative nominee, whether it’s Marshall or another contender. No final decision has been made on abandoning Overton, though there’s quiet acknowledgment internally that her path to confirmation is exceedingly difficult.

In brief

The Scoop Republicans are discussing Sen. Roger Marshall as a potential replacement nominee to lead the Food and Drug Administration as Heidi Overton’s confirmation struggles in the Senate, according to four people familiar with the matter. “Marshall is viewed as an alternative if Heidi can’t make it through,” a Trump administration official told Semafor. The Senate health committee is scheduled to vote on Overton’s nomination on Wednesday.

This is the opening of the story, shared with credit to Semafor. The rest of the report — with every detail — continues on the publisher’s website.

Continue reading at Semafor ↗

Cookie settings

Choose which cookies we may use. You can change this at any time from Cookie settings in the footer. Details of each cookie are in the Cookie Policy.

Strictly necessary

Needed for sign-in, security, payments and remembering these choices. Always on.

Preferences

Remember settings such as dark mode.

Analytics & performance

Help us count visits, understand which pages, devices and countries our readers use, and measure how well the site performs – anonymous and aggregated.

Advertising & marketing

Lets advertising partners show and personalise adverts, measure impressions, clicks and visits, prevent ad fraud and pay us – this is how the free site is funded.

🔔 News notifications

Get headlines from NewsHub on this device — even when the site is closed.

You can switch this off at any time. Works on Android, Windows, Mac and Linux browsers; on iPhone/iPad add the site to your Home Screen first.